DarioHealth(NASDAQ) DRIO

Market Cap$73.40M

Since IPO (2013)-100%

5 Year-97%

1 Year-32%

1 Month-5%

$7.49

+4.46%

+0.32Today

DarioHealth last closing stock price
Metric	Price	Date
Last close	USD 7.49	2026-08-21

DarioHealth stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-1.25%	USD 7.59	2026-08-14
1 month	-5.19%	USD 7.90	2026-07-22
3 month	-4.71%	USD 7.86	2026-05-22
Year to date	-34.18%	USD 11.38	2025-12-31
1 year	-31.91%	USD 11.00	2025-08-21
3 year	-86.67%	USD 56.20	2023-08-22
5 year	-96.69%	USD 226.60	2021-08-20
Since inception	-99.99%	USD 89,640.25	2013-04-09

DarioHealth Financials at a Glance

Market Cap

$73.40M

Revenue (TTM)

$21.00M

Net Income (TTM)

$67.78M

EPS (TTM)

-$7.49

P/E Ratio

-1.00

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$7.49

Volume

4,842

Open

$7.25

Price

$7.49

Volume

4,842

Open

$7.25

Previous Close

$7.49

Daily Range

$7.10 - $8.06

52-Week Range

$5.84 - $17.74

Estimated Earnings Date

Nov 12, 2026

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$7.49

Volume

4,842

Open

$7.25

Previous Close

$7.49

Daily Range

$7.10 - $8.06

52-Week Range

$5.84 - $17.74

Estimated Earnings Date

Nov 12, 2026

DRIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DarioHealth

DarioHealth helps people manage chronic health conditions using digital tools. Its products support diabetes, high blood pressure, and mental health needs. Users track health data, get coaching, and access care from home.

Products and Services

Metabolic Solutions: Digital programs for diabetes, hypertension, and weight management; targets individuals and employers.
Musculoskeletal (MSK) Care: Digital support for joint and muscle pain; included in bundled offerings for employers and health plans.
Behavioral Health: Online mental health tools and coaching; part of integrated care for stress, anxiety, and depression.
Connected Devices: Smart glucose meters, blood pressure cuffs, and digital scales; used for real-time health tracking.
DarioEngage Platform: Central software for care management, data analysis, and user engagement; supports both direct consumers and business clients.

Growth and Expansion

Acquired Twill in 2024, adding behavioral health and engagement technology.
Formed partnership with OneStep in October 2025 for fall-risk and mobility insights.
Launched DarioIQ (AI personalization) and DarioSHIFT (AI efficiency) in 2025.
Expanded GLP-1 weight management programs for employers and pharmaceutical partners in 2025.
Entered Australia, New Zealand, and European Union markets before 2025, broadening international reach.

What Makes DarioHealth Stand Out

DarioHealth combines hardware, software, and coaching for a full-service approach to chronic care. Its platform uses artificial intelligence trained on billions of data points for personalized support. The company offers bundled solutions, reducing complexity for employers and health plans.

Five Things You Need to Know

2025 revenue was $22.36 million, down 17.3% from 2024.
Gross margin rose to 56.6% in 2025, up from 49.1% in 2024.
Operating loss improved to $36.66 million in 2025, from $57.74 million in 2024.
Employer customers grew to 167 in 2025, up from 53 in 2024.

Bottom Line

DarioHealth has shifted from direct-to-consumer roots to a broader business focus. Its integrated digital health platform supports multiple chronic conditions for individuals and organizations.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

165

CEO

Erez Raphael

Website

www.dariohealth.com

Headquarters

New York City, NY 10011, US

DRIO Financials

Key Financial Metrics (TTM)

Gross Margin

56.09%

Operating Margin

-328.83%

Net Income Margin

322.77%

Return on Equity

104.15%

Return on Capital

-36.78%

Return on Assets

70.17%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$73.40M

Shares Outstanding

9.80M

Volume

4.84K

Avg. Volume

17.50K

Financials (TTM)

Gross Profit

$11.78M

Operating Income

-$69.05M

EBITDA

-$29.75M

Operating Cash Flow

-$24.76M

Capital Expenditure

-$136.00K

Free Cash Flow

-$24.89M

Cash & ST Invst.

$14.25M

Total Debt

$32.41M

DarioHealth Performance Analysis

DarioHealth annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 27,656,000	34.8%
2023	2023-12-31	USD 20,352,000	-26.4%
2024	2024-12-31	USD 27,040,000	32.9%
2025	2025-12-31	USD 22,359,000	-17.3%

DarioHealth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-6.7%
Q4	2025-12-31	4.5%
Q1	2026-03-31	6.7%
Q2	2026-06-30	-7.3%

DarioHealth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -50.74	-46.6%
2023	2023-12-31	USD -38.67	-23.8%
2024	2024-12-31	USD -12.27	-68.3%
2025	2025-12-31	USD -10.12	-17.5%

DarioHealth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	5.0%
Q4	2025-12-31	1100.0%
Q1	2026-03-31	-108.9%
Q2	2026-06-30	-400.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$5.18M

-3.6%

Gross Profit

$3.19M

-6.0%

Gross Margin

61.66%

N/A

Market Cap

$73.40M

N/A

Market Cap/Employee

$450.30K

N/A

Employees

163

N/A

Net Income

-$7.92M

+39.0%

EBITDA

-$5.96M

+29.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$14.25M

-35.1%

Total Debt

$32.41M

+2.5%

Accounts Receivable

$1.55M

-71.3%

Inventory

$3.72M

-19.3%

Long Term Debt

$31.84M

+2.3%

Short Term Debt

$572.00K

+12.2%

Return on Assets

70.17%

N/A

Return on Invested Capital

-79.36%

N/A

Free Cash Flow

-$5.53M

+9.0%

Operating Cash Flow

-$5.49M

+8.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NNNNAnbio Biotechnology Class A Ordinary Shares

NNNNAnbio Biotechnology Class A Ordinary Shares$6.81-7.09%

MYGNMyriad Genetics, Inc.

MYGNMyriad Genetics, Inc.$3.20-0.62%

OFIXOrthofix Medical Inc.

OFIXOrthofix Medical Inc.$10.01+0.00%

PACBPacific Biosciences of California, Inc.

PACBPacific Biosciences of California, Inc.$1.35+9.76%

RGNXREGENXBIO Inc.

RGNXREGENXBIO Inc.$10.72-3.07%

FLGTFulgent Genetics, Inc.

FLGTFulgent Genetics, Inc.$19.90-0.10%

VSTMVerastem, Inc.

VSTMVerastem, Inc.$6.89+1.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.77+0.10%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.68+0.06%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.41+0.06%

MARAMara Holdings

MARAMara Holdings$11.26+0.01%

NVDANvidia

NVDANvidia$214.72-0.01%

INTCIntel

INTCIntel$90.07-0.02%

MRNAModerna

MRNAModerna$145.13+0.09%

Questions About DRIO

What is the current price of DarioHealth?

DarioHealth is trading at $7.49 per share.

What is the 52-week range for DarioHealth?

Over the past 52 weeks, DarioHealth has traded between $5.84 and $17.74.

How much debt does DarioHealth have?

As of the most recent reporting period, DarioHealth reported total debt of $32.41M.

How much cash does DarioHealth have on hand?

DarioHealth reported $14.25M in cash and cash equivalents in its most recent financial results.

What is DarioHealth’s dividend yield?

DarioHealth does not currently have a dividend yield.

DarioHealth(NASDAQ) DRIO

DarioHealth Financials at a Glance

DRIO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About DarioHealth

Products and Services

Growth and Expansion

What Makes DarioHealth Stand Out

Five Things You Need to Know

Bottom Line

DRIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

DarioHealth Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DRIO

What is the current price of DarioHealth?

What is the 52-week range for DarioHealth?

How much debt does DarioHealth have?

How much cash does DarioHealth have on hand?

What is DarioHealth’s dividend yield?

Premium Investing Services